Qiagen's Coup in DNA Sample Prep
Executive SummaryQiagen's success in exploiting an overlooked niche in research diagnostics--sample prep for nucleic acid tests--has driven an extraordinary growth story. But its performance has attracted the attention of big diagnostics companies. As it looks to expand into clinical markets, it faces levels of competition it's never seen before.
You may also be interested in...
The World Health Organization has proposed changes to its 2016 guideline on data integrity requirements to provide streamlined information to sponsors and to take account of experience gained to date.